History of Newborn Screening for Cystic Fibrosis—The Early Years

History of Newborn Screening for Cystic Fibrosis—The Early Years

This review summarises the trajectory of neonatal screening strategies for the detection of cystic fibrosis (CF) using the measurement of Immunoreactive Trypsin (IRT) in dried blood spots (DBS) from 1979 until the beginning of the 21st century when newborn screening (NBS) programmes started to sprea...

Full description

Bibliographic Details
Main Authors:	Georges Travert, Mary Heeley, Anthony Heeley
Format:	Article
Language:	English
Published:	MDPI AG 2020-01-01
Series:	International Journal of Neonatal Screening
Subjects:	newborn screening immunoreactive trypsin(ogen) dried blood spot radioimmunoassay dna
Online Access:	https://www.mdpi.com/2409-515X/6/1/8

Similar Items

Newborn Screening for Cystic Fibrosis
Published: (2020)

Early Diagnosis and Intervention in Cystic Fibrosis: Imagining the Unimaginable
by: Andrea M. Coverstone, et al.
Published: (2021-01-01)

Initial Evaluation of Prospective and Parallel Assessments of Cystic Fibrosis Newborn Screening Protocols in Eastern Andalusia: IRT/IRT versus IRT/PAP/IRT
by: Ilham Sadik, et al.
Published: (2019-09-01)

Investigating CFTR gene variations in patient groups with positive newborn screening test results and preliminary clinical diagnosis of cystic fibrosis in the eastern anatolia region of Turkey
by: Ayberk Turkyilmaz, et al.
Published: (2021-06-01)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
by: Matteo Botti, et al.
Published: (2021-01-01)

Cribado neonatal de fibrosis quística: análisis y diferencias de los niveles de tripsina inmunorreactiva en recién nacidos con cribado positivo
by: Marta Arrudi-Moreno, et al.
Published: (2021-07-01)

Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses
by: Olaf Sommerburg, et al.
Published: (2020-03-01)

Extended and Fully Automated Newborn Screening Method for Mass Spectrometry Detection
by: Stefan Gaugler, et al.
Published: (2017-12-01)

Newborn Screening for Krabbe Disease—Illinois Experience: Role of Psychosine in Diagnosis of the Disease
by: Khaja Basheeruddin, et al.
Published: (2021-05-01)

Performance of a Three-Tier (IRT-DNA-IRT) Cystic Fibrosis Screening Algorithm in British Columbia
by: Graham Sinclair, et al.
Published: (2020-06-01)

Elevated Homocysteine after Elevated Propionylcarnitine or Low Methionine in Newborn Screening Is Highly Predictive for Low Vitamin B12 and Holo-Transcobalamin Levels in Newborns
by: Tomaž Rozmarič, et al.
Published: (2020-08-01)

Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses
by: Trine Tangeraas, et al.
Published: (2020-06-01)

At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening
by: Zoltan Lukacs, et al.
Published: (2020-12-01)

Serum trypsin‐like immunoreactivity in dogs with diabetes mellitus
by: Kristen Hamilton, et al.
Published: (2021-07-01)

Programa de triagem neonatal para fibrose cística no estado do Paraná: avaliação após 30 meses de sua implantação Neonatal cystic fibrosis screening program in the state of Paraná: evaluation 30 months after implementation
by: Grégor P. Chermikoski Santos, et al.
Published: (2005-06-01)

Newborn Screening Samples for Diabetes Research: An Underused Resource
by: Jane Frances Grace Lustre Estrella, et al.
Published: (2020-10-01)

Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies
by: Mahya Dezfouli, et al.
Published: (2020-03-01)

Eliciting parental support for the use of newborn blood spots for pediatric research
by: Edwina H. Yeung, et al.
Published: (2016-02-01)

Neonatal screening for cystic fibrosis in São Paulo State, Brazil: a pilot study
by: R. Rodrigues, et al.
Published: (2009-10-01)

Metabolic Serendipities of Expanded Newborn Screening
by: Raquel Yahyaoui, et al.
Published: (2020-08-01)

Ethical Issues Surrounding Newborn Screening
by: R. Rodney Howell
Published: (2021-01-01)

Targeted next generation sequencing for newborn screening of Menkes disease
by: Richard B. Parad, et al.
Published: (2020-09-01)

Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges
by: Laurie D. Smith, et al.
Published: (2020-04-01)

Suitable Specimen Types for Newborn Biochemical Screening-A Summary
by: Kate Hall
Published: (2017-07-01)

Common criteria among States for storage and use of dried blood spot specimens after newborn screening
by: Carlo Petrini, et al.
Published: (2012-06-01)

Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots
by: Christopher J. Collins, et al.
Published: (2020-04-01)

Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization
by: Kevin Stroek, et al.
Published: (2020-07-01)

The Role of Extended <i>CFTR</i> Gene Sequencing in Newborn Screening for Cystic Fibrosis
by: Anne Bergougnoux, et al.
Published: (2020-03-01)

Newborn Screening for Cystic Fibrosis in Russia: A Catalyst for Improved Care
by: Victoria Sherman, et al.
Published: (2020-04-01)

Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
by: Michael H. Gelb, et al.
Published: (2018-12-01)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
by: Anne Munck
Published: (2020-03-01)

Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010
by: J. Gerard Loeber, et al.
Published: (2021-03-01)

Editorial: Newborn Screening for Inborn Errors of Metabolism: Is It Time for a Globalized Perspective Based on Genetic Screening?
by: Mohamed A. Elmonem, et al.
Published: (2021-09-01)

Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools
by: Michael H. Gelb
Published: (2018-07-01)

Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
by: Jon Washburn, et al.
Published: (2020-10-01)

Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies
by: Ana Marcão, et al.
Published: (2018-06-01)

Newborn Thyroid-Stimulating Hormone Dynamicity as per the Antenatal and Perinatal Factors
by: Suprava Patel, et al.
Published: (2021-07-01)

Instability of Acylcarnitines in Stored Dried Blood Spots: The Impact on Retrospective Analysis of Biomarkers for Inborn Errors of Metabolism
by: Willemijn J. van Rijt, et al.
Published: (2020-11-01)

High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots
by: Hamoud Al-Mousa, et al.
Published: (2018-04-01)

Newborn Screening for Sickle Cell Disease: Indian Experience
by: Roshan B. Colah, et al.
Published: (2018-11-01)